SCHEMBL7673264

SCHEMBL7673264

CC(C)OC1(c2ccc(CC[Si](C)(C)C)cc2)CC1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.31
CYP4F2 P78329 1/20 0.30
CYP4A11 Q02928 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673262 0.72
SCHEMBL5736771 0.71 CYP2A6 (0.32)
SCHEMBL15952484 0.71 ESR1 (0.40) CYP4F2CYP4A11
SCHEMBL24380347 0.70 OPRM1 (0.42)
SCHEMBL18326533 0.66 IDO1 (0.45)
SCHEMBL7981188 0.65 ESR2 (0.30)
SCHEMBL21725626 0.64 OPRM1 (0.40)
SCHEMBL24602755 0.63 CYP1A2 (0.52) KCNH2
SCHEMBL17722492 0.63 LPL (0.46)
SCHEMBL13923732 0.62 ESR1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495552-B2 TREATMENT OR PREVENTION OF THE DISEASES AND CONDITIONS WHICH RESPOND TO TREATMENT BY RETINOIDS AND OR WHICH IN HEALTHY MAMMALS, INCLUDING HUMANS, ARE CONTROLLED BY NATURAL RETINOIC ACID. ALLERGAN, INC. 2002-12-17 US disclosed